Managing Oral Chemotherapy
March 2017 - Vol. 14 No. 3 - Page #18

Oral cancer agents (OCAs) are used to treat a wide variety of malignancies (see TABLE 1), and robust drug development in this category continues to spur increased use of these medications. The Food and Drug Administration (FDA) has approved 44 OCAs in the last decade (see TABLE 2 on page 17),1 and there are now over 50 OCAs approved for use in the United States.2 Approximately 25% to 30% of new cancer drugs in development are OCAs.2

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.